Observe Medical ASA – Primary insider notice
Reference is made to the ongoing rights issue of 4,090,909 new shares to a subscription price of NOK 11.00 (the "Offer Shares") in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue"). Navamedic ASA ("NAVA"), represented at the Company's board of directors by Kathrine Gamborg Andreassen, has today, on 25 June 2020, in total subscribed for 1,022,727 Offer Shares of which 853,235 Offer Shares were subscribed through the exercise of subscription rights and 169,492 Offer Shares were over-subscribed. Subject to